Cijepljeni protiv COVID-a i oni koji to žele postati, informacije o testiranjima....

[ina33]

Svjeze vijesti o cjepivima i boosterima (ruzno se kopiralo):

NEW YORK (AP) — Three studies released Friday offered more evidence that COVID-19 vaccines are standing up to the omicron variant, at least among people who received booster shots.
They are the first large U.S. studies to look at vaccine protection against omicron, health officials said.
The papers echo previous research — including studies in Germany, South Africa and the U.K. — indicating available vaccines are less effective against omicron than earlier versions of the coronavirus, but also that boosters doses rev up virus-fighting antibodies to increase the chance of avoiding symptomatic infection.
The first study looked at hospitalizations and emergency room and urgent care center visits in 10 states, from August to this month.

It found vaccine effectiveness was best after three doses of the Pfizer or Moderna vaccines in preventing COVID-19-associated emergency department and urgent care visits. Protection dropped from 94% during the delta wave to 82% during the omicron wave. Protection from just two doses was lower, especially if six months had passed since the second dose.
Officials have stressed the goal of preventing not just infection but severe disease. On that count, some good news: A third dose was at least 90% effective at preventing hospitalizations for COVID-19, both during the delta and omicron periods, the study also found.
The second study focused on COVID-19 case and death rates in 25 states from the beginning of April through Christmas. People who were boosted had the highest protection against coronavirus infection, both during the time delta was dominant and also when omicron was taking over.
Those two articles were published online by the Centers for Disease Control and Prevention.

The Journal of the American Medical Association published the third study, also led by CDC researchers. It looked at people who tested positive for COVID-19 from Dec. 10 to Jan. 1 at more than 4,600 testing sites across the U.S.
Three shots of the Pfizer and Moderna vaccines were about 67% effective against omicron-related symptomatic disease compared with unvaccinated people. Two doses, however, offered no significant protection against omicron when measured several months after completion of the original series, the researchers found.
“It really shows the importance of getting a booster dose,” said the CDC’s Emma Accorsi, one of the study’s authors.
Americans should get boosters if at least five months have passed since they completed their Pfizer or Moderna series, but millions who are eligible have not gotten them.

“If you are eligible for a booster and you haven’t gotten it, you are not up to date and you need to get your booster,” CDC Director Dr. Rochelle Walensky said during a White House briefing Friday.
___
The Associated Press Health & Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
Copyright 2022 The Associated Press. All rights reserved.

Jel ovo znaci da su 2 doze 0 bodova, dzaba si krecio? Il stite od hospitalizacija, al ne i simpt bolesti?. Pitam jer kod nas nije dozvoljeno boostanje 12 plus.

Za decka sad u novinama pise da ne samo da nije imao komorbiditete, nego da je bio sportas, ja sam shvatila da nisu to napisali u smislu da bi se tumacilo da je sport komorbiditet (u smislu napora na scrce il tako nesto), nego kao da je bio super zdrav.

Lili, zao mi je i ne trebas pisati detalje, sve je totalno zbinjujuce i sto je prava istina mozda cemo saznati, mozda ne.

Slazem se s dotom, ko je ful zdrav, svak nesto ima, lili, da tebi je tebi nesto bilo onda bi neko logao reci reko al ona je ipak imala problema s cirkulacijom. Ja doslovno ne znam nikog kome se nesto iscackalo ne bi.

Uz sva upozorenja, omikron je laksi od delte i to je bolje, da nije ne bi brij dnevnih smrti ostao na 50, islo bi na 150.... u tom smislu je to bolje negi prethodni soj.